ロード中...
Lymphoma development and survival in refractory coeliac disease type II: Histological response as prognostic factor
BACKGROUND: Refractory coeliac disease type II (RCDII) frequently transforms into an enteropathy-associated T-cell lymphoma (EATL) and therefore requires intensive treatment. Current evaluated treatment strategies for RCDII include cladribine (2-CdA) and autologous stem cell transplantation (auSCT)....
保存先:
| 出版年: | United European Gastroenterol J |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5349358/ https://ncbi.nlm.nih.gov/pubmed/28344788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640616646529 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|